Dr. Danilkovitch has been with the company since 2003 and has participated in the development of innovative scientific ideas in regenerative medicine. Prior to Osiris, she conducted research at the National Cancer Institute of National Institutes of Health.
Osiris Therapeutics focuses on researching, developing and marketing regenerative medicine products.
More articles on devices:
8 key trends in the North American orthobiologics market
DJO global names Jeanine Kestler EVP, chief HR officer
SpineGuard Q1 revenue up 27%: 6 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
